Leone Patterson's Insider Trades & SAST Disclosures
Leone Patterson's most recent trade in Kalaris Therapeutics Inc. was a trade of 18,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 10, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Leone Patterson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kalaris Therapeutics Inc. | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Apr 2025 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| Zymeworks BC Inc | Leone D Patterson | EVP, Chief Bus & Fin Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2024 | 360,000 | 360,000 | - | - | Stock Option (Right to Buy) | |
| Nkarta Inc | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 205,000 | 205,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | D Patterson Leone | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 35,000 | 95,755 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Leone Patterson D | Chief Fin. and Bus. Officer | Sale of securities on an exchange or to another person at price $ 5.86 per share. | 16 Feb 2024 | 5,201 | 60,755 | - | 5.9 | 30,478 | Common Stock |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Sale of securities on an exchange or to another person at price $ 3.81 per share. | 16 Aug 2023 | 4,452 | 64,542 | - | 3.8 | 16,962 | Common Stock |
| Nkarta Inc | Leone D Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 22,500 | 22,500 | - | - | Stock Option (right to buy) | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 190,000 | 190,000 | - | - | Stock Option (Right to buy) | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 35,000 | 67,000 | - | 0 | Common Stock | |
| Tenaya Therapeutics Inc | Leone D Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 30,000 | 32,000 | - | 0 | Common Stock | |
| Nkarta Inc | Leone D. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | |
| Climb Bio Inc. | Leone D. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 10,000 | 10,000 | - | - | Stock Option (Right To Buy) | |
| Tenaya Therapeutics Inc | Leone D. Patterson | Chief Fin. and Bus. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 66,000 | 66,000 | - | - | Stock Option (Right to buy) | |
| Nkarta Inc | Leone D. Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2021 | 16,511 | 16,511 | - | - | Stock Option (right to buy) | |
| Adverum Biotechnologies Inc | Leone D. Patterson | President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Adverum Biotechnologies Inc | Leone D. Patterson | President and CFO | Sale of securities on an exchange or to another person at price $ 14.10 per share. | 09 Feb 2021 | 12,471 | 98,017 (0%) | 0% | 14.1 | 175,841 | Common Stock |
| Adverum Biotechnologies Inc | Leone D. Patterson | President and CFO | Sale of securities on an exchange or to another person at price $ 14.15 per share. | 09 Feb 2021 | 62 | 97,955 (0%) | 0% | 14.1 | 877 | Common Stock |
| Nkarta Inc | Leone Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 18,300 | 18,300 | - | - | Stock Option (right to buy) | |
| Nkarta Inc | Leone Patterson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2020 | 10,700 | 10,700 | - | - | Stock Option (right to buy) | |
| Adverum Biotechnologies Inc | Leone Patterson | President | Sale of securities on an exchange or to another person at price $ 24.68 per share. | 16 Jun 2020 | 13,171 | 110,488 (0%) | 0% | 24.7 | 325,060 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges